Document is current

Any future updates will be listed below

Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction

Crossref DOI link: https://doi.org/10.1186/s12967-025-06632-x

Published Online: 2025-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark